These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

207 related articles for article (PubMed ID: 321260)

  • 61. Pituitary autonomy in hyperprolactinemic secondary amenorrhea: results of hypothalamic-pituitary testing.
    Healy DL; Pepperell RJ; Stockdale J; Bremner WJ; Burger HG
    J Clin Endocrinol Metab; 1977 May; 44(5):809-19. PubMed ID: 404308
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Galactorrhea and hyperprolactinemia.
    Sakiyama R; Quan M
    Obstet Gynecol Surv; 1983 Dec; 38(12):689-700. PubMed ID: 6361641
    [TBL] [Abstract][Full Text] [Related]  

  • 63. [Bromoergocryptine in the treatment of nonpuerperal galactorrhea].
    Hogh J
    Ugeskr Laeger; 1977 Jul; 139(29):1739-40. PubMed ID: 578342
    [No Abstract]   [Full Text] [Related]  

  • 64. A sequential pituitary stimulation test in normal subjects and in patients with amenorrhea-galactorrhea with pituitary tumors.
    Kletzky OA; Davajan V; Mishell DR; Nicoloff JT; Mims R; March CM; Nakamura RM
    J Clin Endocrinol Metab; 1977 Oct; 45(4):631-40. PubMed ID: 410820
    [No Abstract]   [Full Text] [Related]  

  • 65. [Bromoergocryptine (CB 154) and pregnancy. Notes on 2 cases].
    Pagliani A; Modena G
    Minerva Ginecol; 1979 Jun; 31(6):461-5. PubMed ID: 492588
    [No Abstract]   [Full Text] [Related]  

  • 66. [Serum prolactin level and bromoergocriptine therapy in galactorrhea and oligo- or amenorrhea].
    Baron J; Warenik-Szymankiewicz A; Chwalisz K
    Ginekol Pol; 1981 Jun; 52(6):517-20. PubMed ID: 7197249
    [No Abstract]   [Full Text] [Related]  

  • 67. Hypothalamic-pituitary function in diverse hyperprolactinemic states.
    Boyar RM; Kapen S; Finkelstein JW; Perlow M; Sassin JF; Fukushima DK; Weitzman ED; Hellman L
    J Clin Invest; 1974 Jun; 53(6):1588-98. PubMed ID: 4208470
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Diagnostic and therapeutic modalities in women with galactorrhea.
    Turksoy RN; Farber M; Mitchell GW
    Obstet Gynecol; 1980 Sep; 56(3):323-9. PubMed ID: 6775255
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Clinical response of patients with galactorrhea to pergolide, a potent, long-acting dopaminergic ergot derivative.
    Callaghan JT; Cleary RE; Crabtree R; Lemberger L
    Life Sci; 1981 Jan; 28(1):95-102. PubMed ID: 7194408
    [No Abstract]   [Full Text] [Related]  

  • 70. Effects of CB-154 (2-Br-alpha-ergocryptine) on prolactin and growth hormone release in an acromegalic patient with galactorrhea.
    Ueda G; Sato Y; Yamasaki M; Shioji T; Aono T
    Endocrinol Jpn; 1975 Jun; 22(3):265-8. PubMed ID: 1242128
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The use of bromocriptine in hyperprolactinemia and galactorrhea in Singapore.
    Tsakok FH; Yong YM; Ng CS
    Int J Gynaecol Obstet; 1985 Apr; 23(2):109-13. PubMed ID: 2862070
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Functional evaluation of pituitary reserve in patients with the amenorrhea-galactorrhea syndrome utilizing luteinizing hormone-releasing hormone (LH-RH), L-dopa and chlorpromazine.
    Zárate A; Jacobs LS; Canales ES; Schally AV; De la Cruz A; Soria J; Daughaday WH
    J Clin Endocrinol Metab; 1973 Dec; 37(6):855-9. PubMed ID: 4584924
    [No Abstract]   [Full Text] [Related]  

  • 73. Gonadotropic responsiveness to clomiphene, LRH, estradiol, and bromocriptine in galactorrheic women.
    Forsbach G; Soria J; Canales ES; Guzman V; Cabezas A; Zárate A
    Obstet Gynecol; 1977 Aug; 50(2):139-44. PubMed ID: 327363
    [TBL] [Abstract][Full Text] [Related]  

  • 74. [Effect of acute parlodel load on the prolactin and STH content in patients with various neuroendocrine diseases].
    Mel'nichenko GA; Bol'shakova TD; Gitel' EP; Langner TK; Barkova MV
    Probl Endokrinol (Mosk); 1983; 29(1):19-23. PubMed ID: 6682222
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Evaluation and treatment of hyperprolactinaemia in women of childbearing age.
    Marek J; Zivný J; Srámková J; Kucera E; Kobilková J
    Acta Univ Palacki Olomuc Fac Med; 1981; 101():110-7. PubMed ID: 6242681
    [No Abstract]   [Full Text] [Related]  

  • 76. [Two cases of amenorrhea-galactorrhea with sterility treated with CB 154 (2 bromo-alpha-ergocryptine): ovulation and pregnancy].
    Netter A; Netter AL; Gorins A
    Gynecologie; 1975; 26(2):141-5. PubMed ID: 1164955
    [No Abstract]   [Full Text] [Related]  

  • 77. Bromocriptine in the treatment of hyperolactinemic amenorrhea.
    Badano AR; Miechi HR; Mirkin A; Arcángeli OA; Aparicio NJ; Rodríguez A; Oliva A; Turner D; Figueroa Casas PR
    Fertil Steril; 1979 Feb; 31(2):124-9. PubMed ID: 570131
    [TBL] [Abstract][Full Text] [Related]  

  • 78. The pathophysiology of hyperprolactinemic states and the role of newer ergot compounds in their treatment.
    Frantz AG; Kleinberg DL
    Fed Proc; 1978 Jun; 37(8):2192-7. PubMed ID: 26606
    [TBL] [Abstract][Full Text] [Related]  

  • 79. The use of bromocriptine in the galactorrhoea-amenorrhoea syndromes: the Canadian cooperative study.
    Friesen HG; Tolis G
    Clin Endocrinol (Oxf); 1977; 6 Suppl():91S-99S. PubMed ID: 617073
    [No Abstract]   [Full Text] [Related]  

  • 80. [Use of bromocriptine to induce ovulation in the galactorrhea-amenorrhea syndrome [].
    Hernández Ayup S; Muñoz M; González R; Galache P; Guitrón A; Pancardo RM; Forsbach G
    Rev Invest Clin; 1982; 34(2):121-3. PubMed ID: 7123023
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.